-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on BrightSpring Health, Raises Price Target to $84

Benzinga·11/03/2026 14:40:58
Listen to the news
Guggenheim analyst Jason Cassorla maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and raises the price target from $81 to $84.